Euroapi Company Header Euroapi Company Header

X

CAS 156077-56-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 156077-56-4
Also known as: 156077-56-4, Amy5918, Mfcd32898412, 3-(1,4,7,10-tetraaza-1-cyclododecyl)-1,2,4-butanetriol tetrahydrochloride, Ac-31771, Sy286646
Molecular Formula
C12H32Cl4N4O3
Molecular Weight
422.2  g/mol
InChI Key
FYFSGGAVTBSKBV-UHFFFAOYSA-N

1 2D Structure

CAS 156077-56-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(1,4,7,10-tetrazacyclododec-1-yl)butane-1,2,4-triol;tetrahydrochloride
2.1.2 InChI
InChI=1S/C12H28N4O3.4ClH/c17-9-11(12(19)10-18)16-7-5-14-3-1-13-2-4-15-6-8-16;;;;/h11-15,17-19H,1-10H2;4*1H
2.1.3 InChI Key
FYFSGGAVTBSKBV-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CNCCN(CCNCCN1)C(CO)C(CO)O.Cl.Cl.Cl.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 156077-56-4

2. Amy5918

3. Mfcd32898412

4. 3-(1,4,7,10-tetraaza-1-cyclododecyl)-1,2,4-butanetriol Tetrahydrochloride

5. Ac-31771

6. Sy286646

7. 3-(1,4,7,10-tetrazacyclododec-1-yl)butane-1,2,4-triol;tetrahydrochloride

8. 10-[(1rs,2sr)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecan . 4hcl

2.3 Create Date
2007-12-05
3 Chemical and Physical Properties
Molecular Weight 422.2 g/mol
Molecular Formula C12H32Cl4N4O3
Hydrogen Bond Donor Count10
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass422.119902 g/mol
Monoisotopic Mass420.122852 g/mol
Topological Polar Surface Area100 Ų
Heavy Atom Count23
Formal Charge0
Complexity209
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
Flag India
Digital Content Digital Content
217973-03-0
Gadobutrol
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY